1st Annual Endotoxin Forum

Expanding The Role of rCR in Europe and Beyond

6-7 October 2026 in Prague, Czech Republic

Join this unique forum dedicated to supporting the transition to recombinant BET, featuring keynote speaker Jay Bolden of Eli Lilly, alongside industry experts from leading organizations including Bayer, Thermo Fisher Scientific, ACC and many others.
 

Join pharmaceutical and medical device manufacturers, regulators, technical experts for a two-day forum that will explore practical experiences of transitioning from LAL to recombinant reagents for BET. The forum will include global and European regulatory perspectives on the use of recombinant cascade reagents (rCR), together with insights shared by end users. Participants will have the opportunity to gain practical knowledge, raise questions, and exchange views with industry experts.

The forum will also include an exclusive in-person consultation with ACC technical experts. These consultation sessions will provide attendees with an opportunity to discuss project-related challenges, consider decision-making approaches, and develop strategies to strengthen laboratory operations and support the transition to non-animal-based endotoxin testing.

Whether your organization is beginning to evaluate recombinant reagents or actively implementing them across global laboratories, this forum will provide practical knowledge, peer perspectives, and valuable networking opportunities.

Pre-Register Today!

Hear From Industry Leaders

Veronika Wills

Director, Global Technical Services

Associates of Cape Cod, Inc. (ACC)

Technical Forum Chair

Veronika is a globally recognized subject matter expert and speaker on endotoxin and glucan detection in pharmaceuticals and medical devices. Since joining ACC in 2007, she has specialized in complex-sample testing, method validation, troubleshooting, audits, and the regulatory aspects of bacterial endotoxin testing.

More recently, she has led the assessment, implementation, and automation of recombinant reagent technologies (rCR). She holds a Master's degree in Biochemical Engineering from the University of Chemistry and Technology in Prague, Czech Republic.


Jay Bolden

Senior Director, Global Quality Laboratories

Eli Lilly and Company

Keynote Speaker

A bacterial endotoxins subject matter expert, Jay leads a team with global quality-control oversight for endotoxin, microbiology, and virology test methods, and serves on the U.S. Pharmacopeia (USP) Microbiology Expert Committee.

With more than 26 years at Eli Lilly, he pioneered the company's move to non-animal recombinant endotoxin testing and has authored a book chapter and numerous peer-reviewed articles on endotoxins and recombinant reagents. He holds a B.S. in Biology from Indiana University.


Sandra Weiger

Laboratory Technician

Bayer AG

Remote Speaker

Sandra has been working in the field of endotoxin testing for 27 years. For over 20 of those years, she has been working in QC at Bayer's site in Bergkamen, where she is responsible for endotoxin testing. In 2022, as part of several sustainability projects at the site, Sandra finally got the green light to test alternative methods to the established LAL reagent.


Brett Hoffmeister

Manager, Sustainability Initiatives

Associates of Cape Cod, Inc. (ACC)

Speaker

Brett leads the development of the company's sustainability program and initiatives supporting responsible resource management and the transition to sustainable bacterial endotoxin testing solutions. With more than 22 years of experience in Limulus Amebocyte Lysate (LAL) manufacturing, Brett is ACC's subject matter expert on horseshoe crab conservation and helped develop the company's patented Horseshoe Crab Sustainability Project, which has released more than 1.4 million juvenile horseshoe crabs into Massachusetts coastal waters. Brett also serves as Chair of the Atlantic States Marine Fisheries Commission Horseshoe Crab Advisory Panel.

Why Attend?

Learn from Industry Leaders

Hear directly from pharmaceutical companies and subject matter experts who have successfully implemented recombinant BET methods.

Understand Global Regulatory Progress

Gain insights into evolving pharmacopeial expectations from Europe, the United States, and other global markets.

Explore Real-World Case Studies

See practical examples covering:

  • Water systems
  • Drug products
  • APIs
  • Medical devices
  • Global implementation strategies
Participate in Interactive Discussions

Exchange experiences during roundtable sessions designed to encourage collaboration and problem-solving with peers facing similar challenges.

Exclusive In-Person Sessions With BET experts

Schedule private consultations for an opportunity to discuss project-related challenges, consider decision-making approaches, and develop strategies with ACC's technical experts, to strengthen laboratory operations and support the transition to non-animal-based testing.

  • Validation Strategy
  • Method Implementation
  • Troubleshooting
  • Regulatory Considerations
  • Laboratory Transition Planning

Who Should Attend?

  • QC Microbiologists
  • QC Supervisors and Managers
  • QA Professionals
  • Regulatory Affairs Specialists
  • Pharmaceutical Manufacturing Scientists
  • Validation Specialists
  • Laboratory Managers
  • Technical Consultants
  • Decision-makers Leading Recombinant BET Implementation

Agenda – Day 1, October 6th

The Why & What

Vision, Trends & Industry Direction

Morning

  • Opening Remarks
  • Keynote: The Future of Bacterial Endotoxin Testing
  • Sustainability, Supply Chain Security & Industry Drivers
  • Global Pharmacopeial Updates

Afternoon

  • Industry Survey & Market Trends
  • Customer Case Studies
  • Technical Breakout Sessions
  • Live Demonstrations & Expert Discussions

Evening

  • Networking Reception

Agenda – Day 2, October 7th

The How

Implementation, Validation & Action

Morning

  • Validation & Equivalency Case Studies
  • Implementation Strategies
  • Practical Lessons From Industry Leaders

Afternoon

  • Global rBET Conversion Strategies
  • Interactive Roundtable Discussions
  • Expert Panel & Lightning Talks
  • Closing Remarks

The Venue

Andaz Prague, Czech Republic

Set in the beautifully restored historic Sugar Palace in the heart of Prague, Andaz Prague combines modern luxury with the city's rich architectural heritage. Just steps from Old Town, the venue provides an inspiring environment for scientific collaboration, executive discussions, and professional networking, while offering convenient access to Prague's renowned cultural and historical landmarks.

Pricing & Early Registration

Early Registration​

Register by 31 August 2026 €399 (both days)​

Standard Registration

From 1 September 2026 €599 (both days)​

Registration Includes:​
  • Full access to scientific program​
  • Networking reception​
  • Breakfast and lunch​
  • Refreshments and breaks
  • Exclusive technical consultation session

Pre-Register Today!

We'll keep you informed with:

  • Speaker Updates
  • Program Releases
  • Venue Information